humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
10 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation: 01/09/2010, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation: 01/09/2010, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Liraglutide STADA, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Ablymico, liraglutide, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources